Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 23,726–23,750 of 27,380 studies, newest first · page 950 of 1096.

March 2005 25

  1. 2005-03-31

    Sleep disturbance in mild to moderate Alzheimer's disease

    ✓ Peer-reviewed Risk factors Sleep medicine

    Key finding: Sleep disturbance in AD is associated with other behavioural symptoms, notably aggressiveness. +3 more findings

  2. 2005-03-29

    Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets

    ✓ Peer-reviewed Disease mechanisms The Journal of biological chemistry

    Key finding: Alzheimer disease was associated with significant, although heterogeneous, increases in the concentrations of all evaluated markers.

  3. 2005-03-25

    Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration

    ✓ Peer-reviewed Disparities Journal of medical genetics

    Key finding: The findings support the pathological evidence that underlying variations in MAPT could contribute to disease pathogenesis by subtle effects on gene expression and/or splicing. +3 more findings

  4. 2005-03-24

    Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD

    ✓ Peer-reviewed Mild cognitive impairment Neurobiology of aging

    Key finding: Thirty-one MCI subjects underwent a clinical and neuropsychological examination, and a regional cerebral blood flow (rCBF) SPECT scan at baseline. +4 more findings

  5. 2005-03-23

    Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

    ✓ Peer-reviewed Getting a diagnosis Brain : a journal of neurology

    Key finding: Disease duration in RS was significantly shorter (5.9 versus 9.1 years, P < 0.001) and age at death earlier (72.1 versus 75.5 years, P = 0.01) than in PSP-P. +4 more findings

  6. 2005-03-22

    Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment Dementia and geriatric cognitive disorders

    Key finding: The area under the receiver operator curve (AUC) for AD of the HDS-R (AUC(HDS-R)) and MMSE (AUC(MMSE)) were bigger than 0.90 indicating that both tests are useful for detecting AD. +3 more findings

  7. 2005-03-20

    Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation

    ✓ Peer-reviewed Brain tissue and pathology Nature medicine

    Key finding: A prominent decrease in this neuropeptide also represents a pathological characteristic of Alzheimer disease. +3 more findings

  8. 2005-03-18

    P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: Alternatively, APP can be cleaved within the amyloid beta domain by alpha-secretase releasing the non-amyloidogenic product sAPP alpha, which has been shown to have neuroprotective properties. +3 more findings

  9. 2005-03-17
  10. 2005-03-17

    The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study

    ✓ Peer-reviewed Getting a diagnosis Brain : a journal of neurology

    Key finding: The results showed that cognitive performances of the pre-morbid subjects at baseline were already lower than those of individuals without dementia (1.4 points less on the Mini-Mental State Examination; 1.8 points less on the Benton Visual Retention Test; 4 points less on the Isaacs Set Test and 0.8 points less on the Wechsler Similarities Test). +1 more finding

  11. 2005-03-17
  12. 2005-03-13

    19F and 1H MRI detection of amyloid beta plaques in vivo

    ✓ Peer-reviewed Brain scans and imaging Nature neuroscience

    Key finding: Our findings provide a new direction for specific noninvasive amyloid imaging without the danger of exposure to radiation. +1 more finding

  13. 2005-03-07

    Deaths: leading causes for 2002

    ✓ Peer-reviewed Disparities PubMed

    Key finding: In 2002, the 10 leading causes of death were (in rank order) Diseases of heart; Malignant neoplasms; Cerebrovascular diseases; Chronic lower respiratory diseases; Accidents (unintentional injuries); Diabetes mellitus; Influenza and pneumonia; Alzheimer's disease; Nephritis, nephrotic syndrome and nephrosis; and Septicemia and accounted for about 79 percent of all deaths occurring in the United States. +3 more findings

  14. 2005-03-04

    The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: After BACE cleavage, APP becomes a substrate for gamma-secretase, leading to release of amyloid-beta peptide (Abeta), which accumulates in senile plaques in Alzheimer disease. +3 more findings

  15. 2005-03-03

    Role of oxidative carbonylation in protein quality control and senescence

    ✓ Peer-reviewed Disease mechanisms The EMBO journal

    Key finding: Such carbonylated aggregates can become cytotoxic and have been associated with a large number of age-related disorders, including Parkinson's disease, Alzheimer's disease, and cancer.

  16. 2005-03-01
  17. 2005-03-01

    Role of retinoid signalling in the adult brain

    ✓ Peer-reviewed Prevention and risk Progress in neurobiology

    Key finding: Components of the metabolic pathway for retinoids have been identified in adult brain tissues, suggesting that all-trans-retinoic acid (ATRA) can be synthesized in discrete regions of the brain. +2 more findings

  18. 2005-03-01

    Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors

    ✓ Peer-reviewed Treatments The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: Although abundant reactive microglia are found associated with beta-amyloid (Abeta) plaques in Alzheimer's disease (AD) brains, their contribution to cell loss remains speculative. +3 more findings

  19. 2005-03-01

    Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience

    ✓ Peer-reviewed Brain scans and imaging Radiology

    Key finding: Arterial spin-labeling MR imaging showed regional hypoperfusion with AD, in brain regions similar to those seen in FDG PET and HMPAO SPECT studies of similar populations; this hypoperfusion persists after accounting for underlying cortical gray matter atrophy. +2 more findings

  20. 2005-03-01

    Executive function correlates with walking speed in older persons: the InCHIANTI study

    ✓ Peer-reviewed Vascular contributions Journal of the American Geriatrics Society

    Key finding: In nondemented older persons, executive function is independently associated with tasks of lower extremity function that require high attentional demand. +1 more finding

  21. 2005-03-01

    A systematic review of the scientific evidence for the efficacy of a palliative care approach in advanced dementia

    ✓ Peer-reviewed End-of-life care International psychogeriatrics

    Key finding: Despite the increased interest in palliative care for patients with dementia there is currently little evidence on which to base such an approach.

  22. 2005-03-01

    Detecting depression in Alzheimer's disease: evaluation of four different scales

    ✓ Peer-reviewed Cognitive tests and assessment Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists

    Key finding: The prevalence of depressive symptoms depends on the severity of dementia and the instruments used. +3 more findings

  23. 2005-03-01

    Importance of a comprehensive geriatric assessment in prediction of complications following thoracic surgery in elderly patients

    ✓ Peer-reviewed Cognitive tests and assessment Chest

    Key finding: The prevalence of comorbidities and functional impairment among elderly patients may enhance the risk of operation-related complications, but the importance of these conditions in elderly patients undergoing thoracic surgery remains unclear. +3 more findings

  24. 2005-03-01

    Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment International journal of geriatric psychiatry

    Key finding: From a prospective Memory Clinic cohort including consecutively referred patients, age 60 years or above, and with MMSE score 20 or above, 36 patients with AD and 30 with MCI were included in this study. +3 more findings

  25. 2005-03-01

    Quality of life in dementia--a one-year follow-up study

    ✓ Peer-reviewed Cognitive tests and assessment International journal of geriatric psychiatry

    Key finding: Quality of life (QoL) is becoming an increasingly used outcome measure in both clinical practice and research but little is known about QoL in dementia and how it may change over time. +3 more findings

Browse the library by subject, with the full score breakdown →